Prev Arrow Stocks

Corpay, Inc. ($CPAY) Stock Forecast: Up 10.4% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Corpay, Inc.?

Corpay (NYSE: CPAY) had a bullish market movement today, driven by strong Q4 earnings and a positive outlook for FY 2026 guidance.

Why is Corpay, Inc. going up?

CPAY stock is up 10.4% on Feb 5, 2026 19:02

  • Raised price target to $363.00, indicating a potential upside of 9.40% from the current trading price, reflecting confidence in the company's performance.
  • The launch of the FleetMatics Fuel Card and the partnership with QuikTrip to offer fuel rebates to WEX Fleet One OTR cardholders could potentially boost Corpay's revenue through increased usage of their services.
  • Despite institutional selling by a specific corporation, the increase in holdings by Corpay director Steven T. Stull and the overall positive market sentiment towards the company contributed to the bullish movement in the stock price.
  • The sale of Bio-Techne stock by Representative April McClain Delaney, while unrelated to Corpay, highlights the importance of transparency and ethical considerations in financial transactions, which could indirectly impact investor sentiment in various stocks.

CPAY Price Chart

CPAY Technical Analysis

CPAY News

Royal Bank Of Canada Increases Corpay (NYSE:CPAY) Price Target to $363.00

Royal Bank Of Canada has raised its price target for Corpay (NYSE:CPAY) from $344.00 to $363.00, maintaining a "sector perform" rating. This new target implies a potential upside of 9.40% from the stock's current trading price. The adjustment follows Corpay's recent strong Q4 earnings, which surpassed consensus estimates, and a positive outlook for FY 2026 guidance.

https://www.marketbeat.com/instant-alerts/royal-bank-of-canada-increases-corpay-nysecpay-price-target-to-36300-2026-02-05/

0 News Article Image Royal Bank Of Canada Increases Corpay (NYSE:CPAY) Price Target to $363.00

FleetMatics, FleetCor to Launch GPS-Trackable Branded Fuel Card

FleetMatics and FleetCor Technologies are launching the FleetMatics Fuel Card, a Universal Premium Fleet Card that integrates with FleetMatics' GPS tracking system. This card will provide complete visibility into fuel transactions and usage, allowing fleet managers to track individual vehicle or entire fleet fuel spend. The initiative aims to improve driver productivity, reduce fuel usage, and help control fuel-related expenses, offering flexible billing and strong purchasing controls.

https://www.truckinginfo.com/articles/fleetmatics-fleetcor-to-launch-gps-trackable-branded-fuel-card

1 News Article Image FleetMatics, FleetCor to Launch GPS-Trackable Branded Fuel Card

WEX Card Holders Offered Rebates at QuikTrip Pumps

WEX Fleet One Over-the-Road card holders will now receive fuel rebates at QuikTrip locations due to a new merchant agreement. Cardholders will get a 3-cent rebate for every gallon pumped at any of QuikTrip’s 29 high-speed diesel stations. This partnership aims to provide additional savings for fleets managing driver purchases through the WEX OTR fuel card.

https://www.truckinginfo.com/news/wex-card-holders-offered-rebates-at-quiktrip-pumps

2 News Article Image WEX Card Holders Offered Rebates at QuikTrip Pumps

Recent Report Shows That Rep. April McClain Delaney Sold Up to $210K Worth of Bio-Techne Stock

Representative April McClain Delaney recently filed a sale of Bio-Techne (NASDAQ: TECH) shares, valued between $14,014 and $210,000, with the transaction occurring on January 28, 2026. This sale is part of 163 stock transactions totaling over $387,000 completed by Delaney in the last three years. The article emphasizes the importance of congressional transactions as an investor consideration, noting that the STOCK Act prohibits members of Congress from using private information for personal financial gain.

https://www.benzinga.com/insights/government/26/02/50335816/recent-report-shows-that-rep-april-mcclain-delaney-sold-up-to-210k-worth-of-bio-techne-stock

3 News Article Image Recent Report Shows That Rep. April McClain Delaney Sold Up to $210K Worth of Bio-Techne Stock

Corpay, Inc. $CPAY Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its stake in Corpay, Inc. (CPAY) by 2.3%, selling 8,630 shares, though it still holds 358,885 shares valued at $103.38 million. Concurrently, Corpay director Steven T. Stull increased his holdings by 37.66% through a purchase of 8,000 shares for $2.52 million. Despite the institutional selling, Corpay's stock was trading down approximately 2.4% at $314.71, yet the company reported strong quarterly earnings, beating analyst estimates, and holds a "Moderate Buy" consensus rating with a target price of $369.46.

https://www.marketbeat.com/instant-alerts/filing-corpay-inc-cpay-shares-sold-by-bank-of-new-york-mellon-corp-2026-02-02/

4 News Article Image Corpay, Inc. $CPAY Shares Sold by Bank of New York Mellon Corp

Corpay, Inc. Price History

09.04.2024 - CPAY Stock was down 5.5%

  • CPAY reported its first quarter 2024 financial results, with in-line earnings per share but slightly missing revenue expectations.
  • Aldrich Capital Partners announced the sale of Paymerang to Corpay, potentially impacting investor sentiment.
  • The overall market sentiment towards CPAY might have been influenced by profit-taking after a significant one-year gain in the stock price.
  • Investors may have reacted to recent developments by selling CPAY shares to lock in profits, leading to the bearish movement observed today.

05.11.2025 - CPAY Stock was up 3.4%

  • CPAY's positive market movement could be linked to its participation in the Raymond James TMT and Consumer Conference, which allowed management to engage with investors in a fireside chat, potentially enhancing confidence in the company's future.
  • The increased investment from institutional shareholders such as Franklin Resources Inc. and Prudential Financial Inc. may have also played a role in bolstering positive sentiment around CPAY, demonstrating strong faith in the company's performance and growth opportunities.
  • Strong Q2 earnings, surpassing expectations and offering optimistic guidance for Q4 2025, likely added to investor confidence and drove up the stock price.
  • AI-generated quantitative signals indicating a positive sentiment in the near and mid-term for CPAY might have attracted more traders to the stock, contributing to the bullish momentum witnessed in the market movement today.

05.01.2026 - CPAY Stock was up 11.8%

  • CPAY's stock surge could be linked to its impressive quarterly earnings that surpassed analyst predictions, reflecting a promising future for the company.
  • Director Steven T. Stull's increased holdings in Corpay may have boosted investor confidence, indicating optimism from within the company about its future.
  • The recent decrease in CPAY stake by Bank of New York Mellon Corp by 2.3% initially led to some selling pressure on the stock, but the positive earnings report overshadowed this institutional activity.
  • Despite the institutional selling, overall market sentiment towards CPAY remains positive, driven by the company's strong financial performance and growth prospects.

05.01.2026 - CPAY Stock was up 10.4%

  • Raised price target to $363.00, indicating a potential upside of 9.40% from the current trading price, reflecting confidence in the company's performance.
  • The launch of the FleetMatics Fuel Card and the partnership with QuikTrip to offer fuel rebates to WEX Fleet One OTR cardholders could potentially boost Corpay's revenue through increased usage of their services.
  • Despite institutional selling by a specific corporation, the increase in holdings by Corpay director Steven T. Stull and the overall positive market sentiment towards the company contributed to the bullish movement in the stock price.
  • The sale of Bio-Techne stock by Representative April McClain Delaney, while unrelated to Corpay, highlights the importance of transparency and ethical considerations in financial transactions, which could indirectly impact investor sentiment in various stocks.

03.01.2026 - CPAY Stock was down 5.0%

  • The bearish movement in CPAY's stock price could be attributed to institutional selling by a major financial institution, which decreased its stake in the company by 2.3%.
  • The purchase of CPAY shares by director Steven T. Stull may have provided some support to the stock price, but it was not enough to offset the overall selling pressure.
  • Investors might be reacting negatively to the news of the institutional selling, overshadowing the positive quarterly earnings report and analyst estimates beat.
  • Market sentiment towards CPAY could have been further impacted by external factors or broader market conditions, leading to the bearish movement despite the company's strong performance.

08.07.2024 - CPAY Stock was up 5.1%

  • CPAY stock experienced a strong bullish movement following the release of its Q2 2024 earnings.
  • The company beat analyst estimates for both earnings per share (EPS) and revenue, showcasing its strong financial performance.
  • The positive earnings results, including strong revenue growth and improved retention rates, likely instilled confidence in investors and contributed to the bullish market movement.
  • The better-than-expected financial performance indicates that Corpay Inc is executing its business strategies effectively, leading to increased investor optimism and driving the stock price higher.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.